AIC
BEAT

Ameritas Investment Company’s BioTelemetry, Inc. BEAT Stock Holding History

Ameritas Investment Company’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100
Closed -$6K – 2089
2018
Q4 		$6K Buy
+100
New +$6K ﹤0.01% 1193

Other funds holding BEAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameritas Investment Company's BEAT Position: Q1 2019 in Review

Ameritas Investment Company sold out of BioTelemetry, Inc. (BEAT) in Q1 2019, closing a stake of 100 shares — an estimated $6K sold.

Ameritas Investment Company first reported a position in BEAT in Q4 2018 and held it in 1 quarter. The position peaked at $6K in Q4 2018. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

  • Ameritas Investment Company reported no remaining BioTelemetry, Inc. position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 100 BioTelemetry, Inc. shares in Q1 2019, an estimated $6K.
  • Ameritas Investment Company first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's BioTelemetry, Inc. position peaked at $6K in Q4 2018.
  • 311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.